1-3 of 3
XS Li
Close
Sort by
Journal Articles

In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins

GQ Chen, J Zhu, XG Shi, JH Ni, HJ Zhong, GY Si, XL Jin, W Tang, XS Li, SM Xong, ZX Shen, GL Sun, J Ma, P Zhang, TD Zhang, C Gazin, T Naoe, SJ Chen, ZY Wang, Z Chen
Journal: Blood
Blood (1996) 88 (3): 1052–1061.
https://doi.org/10.1182/blood.V88.3.1052.1052
Published: 1996
Journal Articles

Acute promyelocytic leukemia: clinical relevance of two major PML-RAR alpha isoforms and detection of minimal residual disease by retrotranscriptase/polymerase chain reaction to predict relapse

W Huang, GL Sun, XS Li, Q Cao, Y Lu, GS Jang, FQ Zhang, JR Chai, ZY Wang, S Waxman
Journal: Blood
Blood (1993) 82 (4): 1264–1269.
https://doi.org/10.1182/blood.V82.4.1264.1264
Published: 1993
Journal Articles

Rearrangements in the second intron of the RARA gene are present in a large majority of patients with acute promyelocytic leukemia and are used as molecular marker for retinoic acid-induced leukemic cell differentiation

SJ Chen, YJ Zhu, JH Tong, S Dong, W Huang, Y Chen, WM Xiang, L Zhang, XS Li, GQ Qian
Journal: Blood
Blood (1991) 78 (10): 2696–2701.
https://doi.org/10.1182/blood.V78.10.2696.2696
Published: 1991